1 The preoperative placement of transjugular intrahepatic portosystemic shunt for treatment of a patient with portal hypertension and gastric cancer

2 effects on patients of variations in the implementation of a cardiometabolic risk intervention program in montréal

3 [Continuous precordial murmur caused by an inapparent Cruveilhier-Baumgarten syndrome: bedside diagnosis]

4 Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease

5 Determination of renal blood flow with Doppler ultrasound and the hypertension prevalence and acid-base level in dogs with chronic renal failure

6 Potential use of a “Blood Pressure Action Sheet” for Indonesian patients with hypertension living in rural villages: a qualitative study

7 Exercise as a tool for hypertension and resistant hypertension management: current insights

8 An integrated program with home blood-pressure monitoring and village health volunteers for treating poorly controlled hypertension at the primary care level in an urban community of Thailand

9 Masked hypertension and cardiovascular outcomes: an updated systematic review and meta-analysis

10 Free radical scavenging reverses fructose-induced salt-sensitive hypertension

11 Monitoring and management of hypertension with obesity in adolescents

12 Lercanidipine/enalapril combination in the management of obesity-related hypertension

13 Personalized medicine and treatment approaches in hypertension: current perspectives

14 Clinical use of extended-release oral treprostinil in the treatment of pulmonary arterial hypertension

15 Renal denervation for the management of resistant hypertension

16 Vitamin D status and hypertension: a review

17 Clinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan

18 Which thiazide to choose as add-on therapy for hypertension?

19 Phases in development of an interactive mobile phone-based system to support self-management of hypertension

20 No association between perfluoroalkyl chemicals and hypertension in children

21 Management of patients with resistant hypertension: current treatment options

22 Treating resistant hypertension: role of renal denervation

23 Prevalence of hypertension and its risk factors in southwest Ethiopia: a hospital-based cross-sectional survey

24 Current perspectives on combination therapy in the management of hypertension

25 Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combination

26 Efficacy and tolerability of a single-pill combination of telmisartan 80 mg and hydrochlorothiazide 25 mg according to age, gender, race, hypertension severity, and previous antihypertensive use: planned analyses of a randomized trial

27 New treatment options in the management of hypertension: appraising the potential role of azilsartan medoxomil

28 Efficacy and safety of prolonged-release melatonin for insomnia in middle-aged and elderly patients with hypertension: a combined analysis of controlled clinical trials

29 Integrated control of hypertension by olmesartan medoxomil and hydrochlorothiazide and rationale for combination

30 Clinical utility of fixed-combination telmisartan–amlodipine in the treatment of hypertension

31 Long-term use and tolerability of irbesartan for control of hypertension

32 First-line treatment of hypertension: critical appraisal of potential role of aliskiren and hydrochlorothiazide in a fixed combination

33 Optimal management of hypertension in elderly patients

34 Intravenous clevidipine for management of hypertension

35 Fixed combinations in the pragmatic management of hypertension: focus on aliskiren and hydrochlorothiazide as a single pill

36 Update on the role of candesartan in the optimal management of hypertension and cardiovascular risk reduction

37 Evidence-based approach for managing hypertension in type 2 diabetes

38 Complementary mechanisms of action and rationale for the fixed combination of perindopril and indapamide in treating hypertension – update on clinical utility

39 Current concepts in combination therapy for the treatment of hypertension: combined calcium channel blockers and RAAS inhibitors

40 Valsartan combination therapy in the management of hypertension – patient perspectives and clinical utility

41 Can nocturnal hypertension predict cardiovascular risk?

42 Clinical approach in treatment of resistant hypertension

43 Uncontrolled hypertension and associated factors among adult hypertensive patients on follow-up at Jimma University Teaching and Specialized Hospital: cross-sectional study

44 Cardiac function and hypertension in patients with obstructive sleep apnea

45 Azilsartan alone and in combination for the treatment of hypertension – clinical utility and patient considerations

46 Incidence and outcomes of ocular hypertension from rhegmatogenous retinal detachment surgery in the acute postoperative setting

47 Incidence and outcomes of ocular hypertension from rhegmatogenous retinal detachment surgery in the acute postoperative setting

48 Incidence and outcomes of ocular hypertension from rhegmatogenous retinal detachment surgery in the acute postoperative setting

49 Hydrops Fetalis and Persistent Pulmonary Hypertension in a Neonate with Anti-E Alloimmunization

50 Potential use of a “Blood Pressure Action Sheet” for Indonesian patients with hypertension living in rural villages: a qualitative study

51 Exercise as a tool for hypertension and resistant hypertension management: current insights

52 An integrated program with home blood-pressure monitoring and village health volunteers for treating poorly controlled hypertension at the primary care level in an urban community of Thailand

53 Masked hypertension and cardiovascular outcomes: an updated systematic review and meta-analysis

54 Free radical scavenging reverses fructose-induced salt-sensitive hypertension

55 Monitoring and management of hypertension with obesity in adolescents

56 Lercanidipine/enalapril combination in the management of obesity-related hypertension

57 Personalized medicine and treatment approaches in hypertension: current perspectives

58 Clinical use of extended-release oral treprostinil in the treatment of pulmonary arterial hypertension

59 Renal denervation for the management of resistant hypertension

60 Vitamin D status and hypertension: a review

61 Clinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan

62 Which thiazide to choose as add-on therapy for hypertension?

63 Phases in development of an interactive mobile phone-based system to support self-management of hypertension

64 No association between perfluoroalkyl chemicals and hypertension in children

65 Management of patients with resistant hypertension: current treatment options

66 Treating resistant hypertension: role of renal denervation

67 Prevalence of hypertension and its risk factors in southwest Ethiopia: a hospital-based cross-sectional survey

68 Current perspectives on combination therapy in the management of hypertension

69 Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combination

70 Efficacy and tolerability of a single-pill combination of telmisartan 80 mg and hydrochlorothiazide 25 mg according to age, gender, race, hypertension severity, and previous antihypertensive use: planned analyses of a randomized trial

71 New treatment options in the management of hypertension: appraising the potential role of azilsartan medoxomil

72 Efficacy and safety of prolonged-release melatonin for insomnia in middle-aged and elderly patients with hypertension: a combined analysis of controlled clinical trials

73 Integrated control of hypertension by olmesartan medoxomil and hydrochlorothiazide and rationale for combination

74 Clinical utility of fixed-combination telmisartan–amlodipine in the treatment of hypertension

75 Long-term use and tolerability of irbesartan for control of hypertension

76 First-line treatment of hypertension: critical appraisal of potential role of aliskiren and hydrochlorothiazide in a fixed combination

77 Optimal management of hypertension in elderly patients

78 Intravenous clevidipine for management of hypertension

79 Fixed combinations in the pragmatic management of hypertension: focus on aliskiren and hydrochlorothiazide as a single pill

80 Update on the role of candesartan in the optimal management of hypertension and cardiovascular risk reduction

81 Evidence-based approach for managing hypertension in type 2 diabetes

82 Complementary mechanisms of action and rationale for the fixed combination of perindopril and indapamide in treating hypertension – update on clinical utility

83 Current concepts in combination therapy for the treatment of hypertension: combined calcium channel blockers and RAAS inhibitors

84 Valsartan combination therapy in the management of hypertension – patient perspectives and clinical utility

85 Can nocturnal hypertension predict cardiovascular risk?

86 Clinical approach in treatment of resistant hypertension

87 Heart Rate in Hypertension: Review and Expert Opinion

88 The Mechanism of Acupuncture in Treating Essential Hypertension: A Narrative Review

89 Mobile Phone-Based Intervention in Hypertension Management

90 Urinary Uromodulin Levels and UMOD Variants in Black South Africans with Hypertension-Attributed Chronic Kidney Disease

91 Determination of renal blood flow with Doppler ultrasound and the hypertension prevalence and acid-base level in dogs with chronic renal failure

92 Uncontrolled hypertension and associated factors among adult hypertensive patients on follow-up at Jimma University Teaching and Specialized Hospital: cross-sectional study

93 Cardiac function and hypertension in patients with obstructive sleep apnea

94 Azilsartan alone and in combination for the treatment of hypertension – clinical utility and patient considerations

95 Predictors of isolated systolic hypertension among type 2 diabetes mellitus patients in Jimma University Specialized Hospital, Southwest Ethiopia.

96 Social determinants of hypertension and type-2 diabetes in Kenya: A latent class analysis of a nationally representative sample.

97 The influence of frailty syndrome on medication adherence among elderly patients with hypertension

98 What Contributes to the Regularity of Patients with Hypertension or Diabetes Seeking Health Services? A Pilot Follow-Up, Observational Study in Two Sites in Hubei Province, China

99 Data supporting the angiotensin II activates MEL18 to deSUMOylate HSF2 for hypertension-related heart failure

100 Association of alprazolam with major cardiovascular events in patients with hypertension.

101 Screening for hypertension using emergency department blood pressure measurements can identify patients with undiagnosed hypertension: A systematic review with meta-analysis.

Keyword Connections

Journals

Research Groups

Bibliographies